Heron Therapeutics

- NASDAQ:HRTX
Last Updated 2024-04-23
  • A.P. Pharma develops products using its proprietary biochronomer polymer-based drug delivery platform.
  • Locations

    • Redwood City CA
  • Total Funding (USD)

    24.0 million
  • Security

    Type: ORD
    CUSIP: 427746102
    ISIN: US4277461020
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.